prikaz prve stranice dokumenta Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
  Preuzmi
PDF 671.1 KB
Stručni rad - Pismo uredniku
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
European Respiratory Journal, 59 (2022), 5; 2200388. https://doi.org/10.1183/13993003.00388-2022
(Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet)) Guglielmetti, Lorenzo; Günther, Gunar; Leu, Claude; Cirillo, Daniela; Duarte, Raquel; Garcia-Basteiro, Alberto L.; Goletti, Delia; Janković, Mateja; Kuksa, Liga; Maurer, Florian P.; Méchaï, Frédéric; Tiberi, Simon; van Leth, Frank; Veziris, Nicolas; Lange, Christoph Više autora...

Citirajte ovaj rad

Guglielmetti, L., Günther, G., Leu, C., Cirillo, D., Duarte, R., Garcia Basteiro, A. L. ... Lange, C. (2022). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal, 59. (5). doi: 10.1183/13993003.00388-2022

Guglielmetti, Lorenzo, et al. "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component." European Respiratory Journal, vol. 59, br. 5, 2022. https://doi.org/10.1183/13993003.00388-2022

Guglielmetti, Lorenzo, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia Basteiro, Delia Goletti, et al. "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component." European Respiratory Journal 59, br. 5 (2022). https://doi.org/10.1183/13993003.00388-2022

Guglielmetti, L., et al. (2022) 'Rifapentine access in Europe: growing concerns over key tuberculosis treatment component', European Respiratory Journal, 59(5). doi: 10.1183/13993003.00388-2022

Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia Basteiro AL, i sur.. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal [Internet]. 19.05.2022. [pristupljeno 03.10.2024.];59(5). doi: 10.1183/13993003.00388-2022

L. Guglielmetti, et al., "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component", European Respiratory Journal, vol. 59, br. 5, Svibanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:390162. [Citirano: 03.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:390162
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
AutorLorenzo Guglielmetti
AutorGunar Günther
AutorClaude Leu
AutorDaniela Cirillo
AutorRaquel Duarte
AutorAlberto L. Garcia-Basteiro
AutorDelia Goletti
AutorMateja Janković
AutorLiga Kuksa
AutorFlorian P. Maurer
AutorFrédéric Méchaï
AutorSimon Tiberi
AutorFrank van Leth
AutorNicolas Veziris
AutorChristoph Lange
KolaboracijaStudy Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC)
KolaboracijaEuropean Society of Mycobacteriology (ESM)
KolaboracijaEuropean Respiratory Society (ERS)
KolaboracijaTuberculosis Network European Trials group (TBnet)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Lack of access to rifapentine in Europe denies patients optimal care for active tuberculosis and latent tuberculosis infection, and deprives healthcare providers of adequate tools to pursue tuberculosis control and elimination https://bit.ly/3jz85eh
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Pismo uredniku
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaEuropean Respiratory Journal
Brojčani podacivol. 59, br. 5, 2200388
p-ISSN0903-1936
e-ISSN1399-3003
DOIhttps://doi.org/10.1183/13993003.00388-2022
URN:NBNurn:nbn:hr:105:390162
Datum objave publikacije2022-05-19
URL dokumentahttp://erj.ersjournals.com/lookup/doi/10.1183/13993003.00388-2022
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2022-12-15 10:40:56